SCHEMBL20399092

SCHEMBL20399092

FC(F)(F)c1ncccc1CNc1nc(Cl)nc2ncccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIP4K2C Q8TBX8 2/20 0.46
CD38 P28907 1/20 0.44
PDE5A O76074 2/20 0.39
APP P05067 1/20 0.39
CCR4 P51679 1/20 0.39
CDC7 O00311 1/20 0.38
MAP4K4 O95819 1/20 0.38
PIM1 P11309 1/20 0.38
PRKACA P17612 1/20 0.38
CDK2 P24941 1/20 0.38
GSK3B P49841 1/20 0.38
HIPK2 Q9H2X6 1/20 0.38
MKNK2 Q9HBH9 1/20 0.38
IRAK4 Q9NWZ3 1/20 0.38
PDE2A O00408 3/20 0.37
KDM4E B2RXH2 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
HCAR2 Q8TDS4 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20399159 0.87 PIP4K2C (0.55) PIP4K2CCD38PDE5AAPPCCR4
SCHEMBL20400596 0.87 APP (0.56) CD38PDE5AAPPPIM1CDK2
SCHEMBL20399166 0.85 CD38 (0.48) PIP4K2CCD38CCR4CDC7MAP4K4
SCHEMBL20399464 0.85 CD38 (0.46) PIP4K2CCD38APPCDC7MAP4K4
SCHEMBL20399210 0.85 CD38 (0.48) PIP4K2CCD38CCR4CDC7MAP4K4
SCHEMBL21542069 0.84 CD38 (0.45) PIP4K2CCD38APPCCR4CDC7
SCHEMBL26744187 0.82 PIP4K2C (0.48) PIP4K2CPDE5AAPPCCR4CDC7
SCHEMBL21541997 0.81 CD38 (0.43) PIP4K2CCD38CCR4CDC7MAP4K4
SCHEMBL20399069 0.81 CD38 (0.43) PIP4K2CCD38CDC7MAP4K4PIM1
SCHEMBL21542060 0.81 CCR4 (0.48) PIP4K2CCD38APPCCR4CDC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12545675-B2 Anti-wolbachia pyrido[2,3-d]pyrimidine compounds LIVERPOOL SCHOOL OF TROPICAL MEDICINE (GB) 2026-02-10 US disclosed
US-20230348460-A1 ANTI-WOLBACHIA PYRIDO[2,3-d]PYRIMIDINECOMPOUNDS THE UNIVERSITY OF LIVERPOOL (GB) 2023-11-02 US disclosed
US-20230348460-A1 ANTI-WOLBACHIA PYRIDO[2,3-d]PYRIMIDINECOMPOUNDS THE UNIVERSITY OF LIVERPOOL (GB) 2023-11-02 US disclosed
US-11518760-B2 Anti-Wolbachia pyrido[2,3-d]pyrimidine compounds LIVERPOOL SCHOOL OF TROPICAL MEDICINE (GB) 2022-12-06 US disclosed
US-20190345157-A1 COMPOUNDS EISAI R&D MANAGEMENT CO., LTD. (JP) 2019-11-14 US disclosed
US-20190345157-A1 COMPOUNDS EISAI R&D MANAGEMENT CO., LTD. (JP) 2019-11-14 US disclosed
WO-2018134685-A2 COMPOUNDS LIVERPOOL SCHOOL OF TROPICAL MEDICINE (GB) 2018-07-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12545675-B2 Anti-wolbachia pyrido[2,3-d]pyrimidine compounds CBR1, CBR3, COX6C PIP4K2C 2323/4885CD38 1803/4885PDE5A 4397/4885
US-20230348460-A1 ANTI-WOLBACHIA PYRIDO[2,3-d]PYRIMIDINECOMPOUNDS PWWP2B, WARS1, PNPO PIP4K2C 298/4885CD38 3007/4885PDE5A 2823/4885
US-20190345157-A1 COMPOUNDS ABCB11, LTC4S, AQP1 PIP4K2C 3380/4885CD38 1870/4885PDE5A 819/4885
US-11518760-B2 Anti-Wolbachia pyrido[2,3-d]pyrimidine compounds P2RX5, PNPO, P2RX3 PIP4K2C 221/4885CD38 2960/4885PDE5A 2013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.